메뉴 건너뛰기
Journal of the American Podiatric Medical Association
Volumn 99, Issue 5, 2009, Pages 459-
Could nebivolol be an alternative drug for the treatment of diabetic foot ulcers?
Author keywords

[No Author keywords available]
Indexed keywords

EID: 70350139552     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/0990459     Document Type: Letter
Times cited : (4)
References (8)
  • 1
    • 35448947523 scopus 로고    scopus 로고
    • Statins may be useful in diabetic foot ulceration treatment and prevention
    • GULCAN E, GULCAN A, ERBILEN E, ET AL: Statins may be useful in diabetic foot ulceration treatment and prevention. Med Hypotheses 6: 1313, 2007.
    • (2007) Med. Hypotheses , vol.6 , pp. 1313
    • Gulcan, E.1    Gulcan, A.2    Erbilen, E.3
  • 2
    • 56549096387 scopus 로고    scopus 로고
    • Management and prevention of diabetic foot ulcers and infections: A health economic review
    • CHOW I, LEMOS EV, EINARSON TR: Management and prevention of diabetic foot ulcers and infections: a health economic review. Pharmacoeconomics 12: 1019, 2008.
    • (2008) Pharmacoeconomics , vol.12 , pp. 1019
    • Chow, I.1    Lemos, E.V.2    Einarson, T.R.3
  • 3
    • 0037904408 scopus 로고    scopus 로고
    • Third-generation beta blockers stimulate nitric oxide release from endothelial cells through ATP efflux: A novel mechanism for antihypertensive action
    • KALINOWSKI L, DOBRUCKI LW, SZCZEPANSKA-KONKEL M, ET AL: Third-generation beta blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation 107: 2747, 2003.
    • (2003) Circulation , vol.107 , pp. 2747
    • Kalinowski, L.1    Dobrucki, L.W.2    Szczepanska-Konkel, M.3
  • 4
    • 33747809601 scopus 로고    scopus 로고
    • Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity
    • MASON RP, KUBANT R, JACOB RF, ET AL: Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: role of antioxidant activity. J Cardiovasc Pharmacol 48: 862, 2006.
    • (2006) J. Cardiovasc. Pharmacol , vol.48 , pp. 862
    • Mason, R.P.1    Kubant, R.2    Jacob, R.F.3
  • 5
    • 33646823953 scopus 로고    scopus 로고
    • Characterization of nitric oxide release by nebivolol and its metabolites
    • MAFFEI A, VECCHIONE C, ARETINI A, ET AL: Characterization of nitric oxide release by nebivolol and its metabolites. Am J Hypertens 19: 579, 2006.
    • (2006) Am. J. Hypertens , vol.19 , pp. 579
    • Maffei, A.1    Vecchione, C.2    Aretini, A.3
  • 6
    • 0034622538 scopus 로고    scopus 로고
    • Nebivolol: A third-generation beta-blocker that augments vascular nitric oxide release: Endothelial beta (2) -adrenergic receptor-mediated nitric oxide production
    • BROEDERS MA, DOEVENDANS PA, BEKKERS BC, ET AL: Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta (2) -adrenergic receptor-mediated nitric oxide production. Circulation 102: 677, 2000.
    • (2000) Circulation , vol.102 , pp. 677
    • Broeders, M.A.1    Doevendans, P.A.2    Bekkers, B.C.3
  • 7
    • 70350175430 scopus 로고    scopus 로고
    • Nebivolol might be beneficial in the prevention and treatment of diabetic neuropathy
    • Published online ahead of print December 23
    • GULCAN E, ILHAN D, TOKER S: Nebivolol might be beneficial in the prevention and treatment of diabetic neuropathy. Am J Ther [Published online ahead of print December 23, 2008).
    • (2008) Am. J. Ther.
    • Gulcan, E.1    Ilhan, D.2    Toker, S.3
  • 8
    • 0036179826 scopus 로고    scopus 로고
    • Effects of antihypertensive drugs on endothelial dysfunction: Clinical implications
    • TADDEI S, VIRDIS A, GHIADONI L, ET AL: Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 62: 265, 2002.
    • (2002) Drugs , vol.62 , pp. 265
    • Taddei, S.1    Virdis, A.2    Ghiadoni, L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.